Correction: Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer.

Autor: Gao M; Department of Surgery, University of Kentucky, Lexington, KY, USA.; Markey Cancer Center, University of Kentucky, Lexington, KY, USA., Lin M; Department of Surgery, University of Kentucky, Lexington, KY, USA., Moffitt RA; Department of Pathology, State University of New York, Stony Brook, NY, USA., Salazar MA; Department of Experimental Therapeutics, City of Hope, Duarte, CA, USA., Park J; Department of Radiology, University of Iowa, Iowa City, IA, USA., Vacirca J; New York Cancer Specialists, East Setauket, New York, NY, USA., Huang C; Departments of Radiology, State University of New York, Stony Brook, NY, USA.; Departments of Psychiatry, State University of New York, Stony Brook, NY, USA., Shroyer KR; Department of Pathology, State University of New York, Stony Brook, NY, USA., Choi M; Departments of Medicine, State University of New York, Stony Brook, NY, USA., Georgakis GV; Departments of Surgery, State University of New York, Stony Brook, NY, USA., Sasson AR; Departments of Surgery, State University of New York, Stony Brook, NY, USA., Talamini MA; Departments of Surgery, State University of New York, Stony Brook, NY, USA., Kim J; Department of Surgery, University of Kentucky, Lexington, KY, USA. joekim7@yahoo.com.; Markey Cancer Center, University of Kentucky, Lexington, KY, USA. joekim7@yahoo.com.
Jazyk: angličtina
Zdroj: British journal of cancer [Br J Cancer] 2020 Aug; Vol. 123 (3), pp. 495.
DOI: 10.1038/s41416-020-0879-6
Abstrakt: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Databáze: MEDLINE